Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 15, 2025 08:00 ET | Source: Aspargo Laboratories, Inc.

Aspargo Labs CEO to Participate in Panel Discussion at the American Urological Association Innovation Nexus Conference

NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a Pharmaceutical and MedTech company focused on converting the world's most meaningful medications...
April 07, 2025 08:00 ET | Source: Aspargo Laboratories, Inc.

Aspargo Labs Expands Global Leadership Team

NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a specialty pharmaceutical and MedTech company focused on converting the world's most meaningful...
February 26, 2025 08:00 ET | Source: Aspargo Laboratories, Inc.

Aspargo Labs Appoints Mario Guralnik as Chief Regulatory Officer

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. (“Aspargo Labs” or the “Company”), a specialty pharmaceutical and MedTech company focused on converting the world’s most meaningful...
January 27, 2025 08:00 ET | Source: Aspargo Laboratories, Inc.

Aspargo Labs Appoints Harold D. Tamayo as Chief Financial Officer

NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc., (“Aspargo Labs” or the “Company”), a specialty pharmacy and MedTech company focused on converting the world’s most meaningful...
December 20, 2024 08:00 ET | Source: Aspargo Laboratories, Inc.

Aspargo Labs Appoints General Managers in Spain and Germany to Drive International Expansion

NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. (“Aspargo Labs” or the “Company”), a specialty pharmacy and MedTech company focused on reformulating the world’s most meaningful Rx and...
November 19, 2024 08:00 ET | Source: Aspargo Laboratories, Inc.

Aspargo Labs Appoints Chief Marketing Officer

NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. (“Aspargo Labs” or the “Company”), a specialty pharmacy and MedTech company focused on reformulating the world’s most meaningful Rx and...
December 05, 2023 08:00 ET | Source: Aspargo Laboratories, Inc.

Aspargo Laboratories Inc. Announces Completion of Dosing of All Subjects in Sildenafil Oral Suspension Bioavailability Study and Initiation of Dosing in Companion Food-Effect Study

Dosing complete for 53 subjects in Sildenafil Oral Suspension Bioavailability StudyInitiated dosing in 38 subjects in Sildenafil Oral Suspension Food-Effect StudyTop-line data from both studies...
September 19, 2023 08:00 ET | Source: Aspargo Laboratories, Inc.

Aspargo Laboratories Inc. Announces Initial Dosing of All Subjects in Bioavailability Study for Sildenafil Oral Suspension

Study will compare bioavailability of Sildenafil Oral Suspension and Viagra® tablets under fasted conditionsCompanion study will evaluate the effects of food on the bioavailability of Sildenafil Oral...
September 05, 2023 08:00 ET | Source: Aspargo Laboratories, Inc.

Aspargo Laboratories Announces IND Clearance by U.S. FDA, Enabling Launch of Bioequivalence and Food-Effect Studies for Sildenafil Oral Spray

Company plans to initiate clinical trials in September 2023 to compare Sildenafil Oral Spray to Viagra® tablets, and effect of dose administration under fasted versus fed conditionsRepresents...
August 01, 2023 08:00 ET | Source: Aspargo Laboratories, Inc.

Aspargo Laboratories, Inc. Announces Filing of Its Investigational New Drug Application for Sildenafil Oral Spray

Planned bioequivalence study in healthy adult male subjects will compare the rate and extent of absorption of ASP-001 (Sildenafil Oral Spray) versus Viagra® tabletsCompanion food-effect study will...